Lazard Asset Management LLC Regenxbio Inc. Transaction History

Lazard Asset Management LLC

$63.4 Billion
Q2 2025

A detailed history of Lazard Asset Management LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 45,398 shares of RGNX stock, worth $573,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,398

Holding current value

$573,830

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.31 - $10.4 $241,063 - $472,139	45,398 New	45,398 $372,000
Q4 2024 Feb 14, 2025	SELL	$7.23 - $11.56 $54,839 - $87,682	-7,585 Reduced 99.41%	45 $0
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $78,790 - $108,083	7,511 Added 6311.76%	7,630 $80,000
Q2 2024 Aug 14, 2024	SELL	$11.51 - $21.53 $19,014 - $35,567	-1,652 Reduced 93.28%	119 $1,000
Q1 2024 May 14, 2024	SELL	$12.17 - $24.61 $118,487 - $239,602	-9,736 Reduced 84.61%	1,771 $36,000
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $114,940 - $185,651	8,917 Added 344.29%	11,507 $206,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $1,761 - $2,138	107 Added 4.31%	2,590 $42,000
Q2 2023 Aug 14, 2023	SELL	$17.23 - $21.71 $62,562 - $78,829	-3,631 Reduced 59.39%	2,483 $49,000
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $56,228 - $76,350	-3,110 Reduced 33.72%	6,114 $114,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $20,950 - $25,397	-1,027 Reduced 10.02%	9,224 $209,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $11,256 - $17,695	505 Added 5.18%	10,251 $270,000
Q2 2022 Aug 09, 2022	BUY	$19.35 - $35.04 $61,107 - $110,656	3,158 Added 47.94%	9,746 $240,000
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $111,971 - $156,041	4,548 Added 222.94%	6,588 $218,000
Q4 2021 Feb 09, 2022	SELL	$30.19 - $40.28 $54,311 - $72,463	-1,799 Reduced 46.86%	2,040 $66,000
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $37,613 - $59,064	1,293 Added 50.79%	3,839 $160,000
Q2 2021 Aug 12, 2021	BUY	$32.46 - $40.48 $80,955 - $100,957	2,494 Added 4796.15%	2,546 $98,000
Q1 2021 May 14, 2021	SELL	$33.61 - $49.95 $57,372 - $85,264	-1,707 Reduced 97.04%	52 $1,000
Q4 2020 Feb 11, 2021	BUY	$26.52 - $49.35 $9,441 - $17,568	356 Added 25.37%	1,759 $79,000
Q3 2020 Nov 13, 2020	SELL	$27.01 - $40.26 $15,368 - $22,907	-569 Reduced 28.85%	1,403 $38,000
Q2 2020 Aug 13, 2020	BUY	$27.75 - $43.44 $54,723 - $85,663	1,972 New	1,972 $72,000
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $32,164 - $81,083	-1,496 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$34.54 - $44.87 $51,671 - $67,125	1,496 New	1,496 $61,000
Q3 2018 Nov 13, 2018	SELL	$65.0 - $82.15 $1.23 Million - $1.56 Million	-18,932 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$27.2 - $74.35 $514,950 - $1.41 Million	18,932 New	18,932 $1.36 Million

Others Institutions Holding RGNX

# of Institutions

183

Shares Held

45.3M

Call Options Held

103K

Put Options Held

100K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $546M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Regenxbio Inc. Transaction History